Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19

JQ **e, A Prats-Uribe, Q Feng, YH Wang… - JAMA internal …, 2022 - jamanetwork.com
Importance The risk of venous thromboembolism (VTE) in ambulatory COVID-19 is
controversial. In addition, the association of vaccination with COVID-19–related VTE and …

[HTML][HTML] Hereditary Thrombophilia in the Era of COVID-19

OV Badulescu, PD Sirbu, N Filip, G Bordeianu… - Healthcare, 2022 - mdpi.com
Thrombophilia, also called hypercoagulability or prothrombotic condition, usually reflects a
certain imbalance that occurs either in the coagulation cascade or in the anticoagulation …

What we know (and do not know) regarding the pathogenesis of pulmonary thrombosis in COVID-19

G Lippi, EJ Favaloro - Seminars in Thrombosis and Hemostasis, 2023 - thieme-connect.com
The clinical course of coronavirus disease 2019 (COVID-19) is often complicated by the
onset of venous thrombosis and thromboembolism (VTE), encompassing also pulmonary …

Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination

A Yalcinkaya, M Cavalli, M Aranda-Guillén… - Scientific Reports, 2024 - nature.com
Abstract While Coronavirus disease 2019 (COVID-19) vaccines have proven to be both
effective and generally safe, rare but severe adverse events following immunization (AEFIs) …

Thrombophilia genetic mutations and their relation to disease severity among patients with COVID-19

H Moness, SO Mousa, SO Mousa, NM Adel… - PLoS …, 2024 - journals.plos.org
Objectives Patients with COVID-19 infection appear to develop virus-induced
hypercoagulability resulting in numerous thrombotic events. The aim of the present study …

Role of genetic thrombophilia markers in thrombosis events in elderly patients with COVID-19

I Fevraleva, D Mamchich, D Vinogradov, Y Chabaeva… - Genes, 2023 - mdpi.com
Thrombosis is an extremely dangerous complication in elderly patients with COVID-19.
Since the first months of the pandemic, anticoagulants have been mandatory in treatment …

Overview of COVID-19's relationship with thrombophilia proteins

S Aydin, K Ugur, H Yalcin, İ Sahin, RF Akkoc… - Turkish Journal of …, 2021 - degruyter.com
COVID-19 is the most devastating pandemic situation we have experienced in our age,
affecting all systems. Although it affects all systems, it shows its most important effect through …

[PDF][PDF] Protein S deficiency and COVID-19: A brutal combination leading to acute submassive bilateral pulmonary embolism

Y Chirumamilla, Y Almerstani, H Marcus, G Bachuwa - Cureus, 2023 - cureus.com
Protein S deficiency is a form of inherited thrombophilia that occurs due to low levels of or
improper function of protein S. The role of protein S is to inactivate procoagulant factors, and …

Inherited thrombophilia: undetected comorbidity complicating COVID-19 infection

D Khatana, P Rani, S Jain, R Gupta… - American Journal of …, 2023 - pmc.ncbi.nlm.nih.gov
The relation between the severity of COVID-19 and coexisting undiagnosed underlying
thrombophilic conditions is not yet established. It may be possible that undiagnosed …

Dermatological Manifestations in COVID-19: A Case Study of SARS-CoV-2 Infection in a Genetic Thrombophilic Patient with Mthfr Mutation

GG Celestino, MK Amarante, EC Vespero, ER Tavares… - Pathogens, 2023 - mdpi.com
The present case study describes the dermatological manifestations of COVID-19 in a
patient with genetic thrombophilia (MTHFR–C677T mutation) and the identification of a …